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Summary 
Rat antizyme gene expression requires programmed, 
ribosomal frameshiffing. A novel autoregulatory mech- 
anism enables modulation of frameshiffing according 
to the cellular concentration of polyamines. Antizyme 
binds to, and destabilizes, ornithine decarboxylase, a 
key enzyme in polyamine synthesis. Rapid degrada- 
tion ensues, thus completing a regulatory circuit. In 
vitro experiments with a fusion construct using reticu- 
Iocyte lysates demonstrate polyamine-dependent ex- 
pression with a frameshift efficiency of 19% at the opti- 
mal concentration of spermidine. The frameshift is +1 
and occurs at the codon just preceding the terminator 
of the initiating frame. Both the termination codon of 
the initiating frame and a pseudoknot downstream in 
the mRNA have a stimulatory effect. The shift site se- 
quence, UCC-UGA-U, is not similar to other known 
frameshift sites. The mechanism does not seem to in- 
volve re-pairing of peptidyl-tRNA in the new frame but 
rather reading or occlusion of a fourth base. 
Introduction 
In decoding certain mRNAs, a high proportion of ribo- 
somes shift from the initiating reading frame to one of the 
other two frames in response to signals in the mRNA. 
This programmed ribosomal frameshifting constitutes an 
important part of recoding or reprogrammed genetic de- 
coding (Gesteland et al., 1992). Programmed frameshift- 
ing is well known in the decoding of compact genomes 
such as retrotransposons and bacterial, yeast, plant, and 
animal viruses (especially retroviruses), but only a few 
cases are known in cellular genes. The classic case of 
the latter is the autoregulatory frameshifting involved in 
decoding the Escherichia coli release factor 2 (RF2) gene 
(Craigen and Caskey, 1986; Weiss et al., 1987; Curran 
and Yarus, 1988). Until now, programmed frameshifting 
was unknown in decoding animal genes. We describe the 
autoregulatory involvement of frameshifting in decoding 
mammalian antizyme and show that not only is the frame- 
shifting different from that used by mammalian viruses, it 
is distinct from all other known types of frameshifting. 
Antizyme is a polyamine-inducible protein that binds to, 
and inhibits, ornithine decarboxylase (ODC) (reviewed by 
Hayashi and Canellakis, 1989). ODC is a key enzyme for 
polyamine biosynthesis in animal cells (reviewed by Pegg, 
1986). It converts ornithine to a diamine, putrescine, which 
in turn leads to spermidine and spermine. ODC has the 
fastest turnover rate of any mammalian enzyme, with a 
half-life of 10-60 min (Russell and Snyder, 1969). Eleva- 
tion of cellular polyamine levels accelerates degradation 
of ODC (Hayashi, 1989), and early results suggested that 
antizyme is essential in this process (Murakami et al., 
1985; Murakami and Hayashi, 1985). This was confirmed 
by using antizyme expressed from a cDNA clone (Mura- 
kami et al., 1992a, 1992b), and the degradation was shown 
to be catalyzed by 26S proteasome without ubiquitination 
(Murakami et al., 1992c; Tokunaga et al., 1994). The C-ter- 
minal half of antizyme binds to ODC, inducing a conforma- 
tional change (Li and Coffino, 1993), allowing an additional 
internal sequence in antizyme to promote destabilization 
of ODC (Li and Coffino, 1994; Ichiba et al., 1994). Conse- 
quently, ODC is not only short-lived like other proteins 
that control important cellular processes (Goldberg and 
St. John, 1976), but its turnover is also regulated. Though 
mechanistically distinct, the induced destabilization by 
antizyme is analogous to that of human papillomavirus 
oncoprotein E6 action on the tumor suppressor p53 
(Scheffner et al., 1990). Antizyme has a second function: it 
also represses polyamine uptake, thereby enabling sharper 
shutdown of polyamine accumulation in cells (Mitchell et 
al., 1994; Suzuki et al., 1994). 
Several features of antizyme induction by polyamines 
point to regulation of antizyme translation. Antizyme syn- 
thesis is inhibited by cycloheximide but not actinomycin 
D (Fong et al., 1976; Matsufuji et al., 1990a). While only 
a minute amount of antizyme is present in mammalian 
tissues (around 1 ppm of soluble protein), its mRNA level 
is relatively high and not further elevated by polyamines 
(Matsufuji et al., 1990b). Polyamines interact with nucleic 
acids and are important for protein synthesis, particularly 
for accurate decoding (Atkins et al., 1975; reviewed by 
Tabor and Tabor, 1984). However, the polyamine action 
on antizyme translation is specific for frameshifting. The 
mechanism involved is addressed here. 
A partial cDNA clone for antizyme, Zl, has been isolated 
(Matsufuji et al., 1990b). Although Z1 lacks an in-phase 
AUG initiator along with its 5' untranslated region and 
some 5' part of the coding region, its open reading frame 
(ORF) potentially encodes active antizyme. This was shown 
by production of active and immunoreactive protein from 
a derivative of the cDNA supplemented with an appropri- 
ately placed lac promoter and a translational initiator in 
E. coil (Matsufuji et al., 1990b). Active antizyme was also 
produced in transfected mammalian cells from the cDNA 
driven by mouse mammary tumor virus long terminal re- 
peat promoter (Murakami et al., 1992a). In this cell line, 
antizyme synthesis is dependent on dexamethasone but 
is not further stimulated by polyamines, implying that the 
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Figure 1. Nucleotide Sequence of Antizyme-Coding Region and Po- 
tential Amino Acid Sequences 
Asterisks denote the termination codons. Nucleotides are numbered 
starting from the first ATG. All of the antizyme constructs described 
follow this numbering system. Two initiator codons are boxed. The 
underlined nucleotide was deleted in the in-frame control, AT205. The 
5' endpoint of the partial-length cDNA (Zl) is shown. 
proximal gene segment missing from Zl is important for 
the translational regulation by polyamines. To determine 
the entire mRNA sequence, a genomic clone was isolated 
(Miyazaki et al., 1992) in parallel with full-length cDNA 
clones (see Results). As reported here, an analysis of 
these clones revealed that antizyme is decoded from two 
ORFs by ribosomal frameshifting that is dependent on 
polyamine levels. These conclusions were reported pre- 
viously (Gesteland et al., 1992). Rom and Kahana (1994) 
reported polyamine-dependent frameshifting of antizyme 
expression using one of these same clones. 
Results 
Expression of Antizyme mRNA 
Requires Frameshifting 
Two full-length cDNA clones were isolated from a rat liver 
library and sequenced. They are identical except that they 
have different 5' endpoints, and they contain the exact 
sequence present in the partial cDNA clone Z1 (see Intro- 
duction). Their sequence is also identical with that of the 
exons in the genomic clone that was determined by $1 
analysis with the partial cDNA clone (Miyazaki et al., 1992). 
This result is consistent with the lack of editing of the tran- 
scripts. 
Two major ORFs are evident (Figure 1). ORF1, begin- 
ning at the first AUG, has a length of 204 nt terminating 
with UGA and could encode a polypeptide of 7441 Da. It is 
not sufficient o encode antizyme whose relative molecular 
mass (Mr) is18-19 kDa as determined by SDS-PAGE on 
purified preparations (Kitani and Fujisawa, 1984; Matsufuji 
et al., 1990a). ORF2 overlaps most of ORF1 by 198 nt 
and consists of 675 nt (adequate to encode a protein of 
24,321 Da) but does not have an obvious initiation codon; 
its sole AUG is 14 codons from the 3' end. The original 
cDNA clone, Zl ,  contained most of ORF2, which, when 
experimentally expressed, produced active protein (see 
Introduction). 
There are several possible explanations for the expres- 
sion of antizyme from this mRNA, including unusual ribo- 
some initiation, RNA editing, and posttranscriptional modi- 
fication such as transpeptidation. However, there is an 
increasing number of examples of programmed ribosomal 
frameshifting to express one protein from overlapping 
ORFs. The experiments presented here address the 
frameshift model and rule out the other possibilities, as 
discussed below. 
To investigate frameshifting, the complete two ORFs 
were inserted downstream of bacteriophage T7 RNA pro- 
moter so that in vitro synthesized RNA could be made and 
then translated in rabbit reticulocyte lysates. As a control, 
an in-frame construct, AT205, was prepared by deleting 
the T at nucleotide 205 (underlined in Figure 1), which 
removes the stop codon at the end of ORF1, creating a 
continuous ORF with the whole ORF1 and the nonoverlap- 
ping part of ORF2. The proteins synthesized with or with- 
out the addition of spermidine were compared because 
of the unusual involvement of polyamines in antizyme ex- 
pression in vivo. 
[35S]Methionine-labeled products were analyzed by 
SDS-PAGE (Figure 2A). Translation of the control mRNA 
with ORF1 and ORF2 in the same frame resulted in two 
major products (of Mr 29 kDa and 23 kDa), and their synthe- 
sis was not stimulated by spermidine. The same two prod- 
ucts are seen from the wild-type mRNA (ORF1 and ORF2 
out of frame), but spermidine greatly enhanced the ap- 
pearance of both proteins. The gel patterns are the same 
with or without precipitation with antizyme antibody (data 
not shown). 
The two products from both wild-type and in-frame 
mRNAs result from initiation at the first and second (nucle- 
otides 100-102) AUG codons in ORF1 (boxed in Figure 
1). This is shown by the following two experiments. With 
mutational analysis (Figure 2B), elimination of the first 
AUG (AUG1) abolished the 29 kDa band (this change also 
enhanced a band of - 26 kDa, probably through increas- 
ing a non-AUG initiation at an unknown position). Elimina- 
tion of the second AUG (AUG2) abolished the 23 kDa band. 
N-terminal sequence analysis of the two proteins by Ed- 
man degradation of [3H]leucine- or [3H]valine-labeled ma- 
terial gave sequences Val-X-X-X-Leu-X-X-X-Leu-X-X for 
the 29 kDa band and X-Leu-Leu-X-X-X-X-X-X-X-X (no va- 
line) for the 23 kDa band. These are consistent with the 
predicted sequences with removal of the N-terminal methi- 
onine. Initiation of translation of the wild-type mRNA at 
these two AUG codons, terminating at the in-frame UGA, 
should give polypeptides of 67 and 34 amino acids (7311 
and 3570 Da, respectively); at least the former should be 
detected by the gel assay but was barely seen (data not 
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Figure 2. Translation of Antizyme mRNAs in Rabbit Reticulocyte 
Lysate 
(A) The wild-type (WT) and AT205 mRNAs were translated with (+Spd) 
or without (-Spd) addition of 0.8 mM spermidine. The products were 
immunoprecipitated with the anti-antizyme or preimmune IgG (con- 
trol), separated on 15% SDS-PAGE, and processed for fluorography. 
The positions of Mr markers are indicated on the left. 
(B) Mutational analysis of AUG codons. Each or both of the two AUG 
codons of ORF1 located at nucleotides 1-3 and 100-102 (boxed in 
Figure 1) was changed to AUC and translated as above in the presence 
of 0.8 mM spermidine. 
(C) Effect of spermidine on translation in the rabbit reticulocyte lysates. 
The wild-type and AT205 mRNAs were translated in the presence 
of indicated concentrations of exogenous spermidine. Translation of 
albumin (AIb) RNA from rat liver poly(A) ÷ RNA was also tested with 
the same conditions. 
(D) Diagram of BMV coat-antizyme fusion construct with the wild-type 
antizyme (wild-type fusion). Essential components and expected 
lengths of the products of termination (TERM) and +1 frameshifting 
(FS) are indicated. T7 denotes the T7 promoter. 
(E) Autoradiograms of translation products from fusion constructs. 
Left, the wild-type (WT) or in-frame (IN) fusion mRNA was translated 
in a reticulocyte lysate supplemented with (+) or without (-) 0.6 mM 
spermidine (Spd) and fractionated without immunoprecipitation. Cen- 
ter, translation products synthesized in the presence of 0.6 mM exoge- 
nous spermidine were immunoprecipitated with antibody against BMV 
or antizyme (AZ), or preimmune IgG (control). Right, translation of 
5' deletion mutants of antizyme. Constructs were translated in the 
presence of 0.6 mM exogenous spermidine and separated without 
immunoprecipitation. All the protein products were separated on 
12.5% SDS-PAGE. The positions of the frameshift (FS) and termina- 
tion (TERM) products are indicated. 
shown), suggesting that it may be rapidly degraded in retic- 
ulocyte lysates. (However, this region of the gel is ob- 
scured by the great excess of globin in reticulocyte lysates. 
A 7 kDa protein can be discerned if the wild-type RNA is 
translated in extracts from wheat germ [data not shown].) 
Translation products of these mRNAs do contain the 
ORF2 sequence: they react with an antibody specific to 
the bacterial ORF2 product (Figure 2A), and they exhibit 
antizyme activity by binding to, and inhibiting, ODC (data 
not shown), which is known to be encoded wholly within 
the nonoverlapped part of ORF2 (nucleotides 206-682) 
(Matsufuji et al., 1990b; Murakami et al., 1992a). These 
findings, taken together with the determination of ORF1 
N-terminal sequences, indicate that the reading frame for 
antizyme translation changes from ORF1 to ORF2 at some 
position within the overlap of the two ORFs. ORF2 does 
not appear to be expressed independently of initiation at 
ORF1, arguing against subsequent transpeptidation of 
ORF1 and ORF2 products. 
Spermidine affected synthesis of antizyme products 
from the wild-type RNA. This preparation of reticulocyte 
lysate endogenously contained 0.36 mM spermidine and 
0.03 mM spermine as final concentrations for translation. 
At the optimal concentration of 0.8 mM of exogenous per- 
midine, there is a 10-fold stimulation in antizyme synthesis 
over the level seen with no added spermidine, bringing 
the efficiency up to about 30% of the in-frame control (Fig- 
ure 2C; comparison with the in-frame control is necessary, 
since the small non-shift ermination product cannot be 
detected). In contrast, translation of the in-frame mRNA 
was efficient even at low spermidine concentrations and 
was somewhat suppressed by increasing concentrations 
of spermidine. This inhibition is nonspecific, as translation 
of albumin mRNA shows the same effect. Spermine and 
putrescine also stimulated synthesis of antizyme from 
wild-type mRNA, with optimal concentrations of 0.12 mM 
and 4 mM, respectively, whereas magnesium (1-4 mM) 
did not show the effect (data not shown). These data show 
that the polyamine stimulatory effect is specific to transla- 
tion of the wild-type mRNA, which requires an unusual 
translocation event. Presumably the ribosome initiation 
rate is the same on both mRNAs, and it is the frameshift 
event that responds to polyamine addition. 
To reveal the product of the wild-type mRNA that termi- 
nates at the UGA in ORF1 and to get a measure of'the 
efficiency of transition from ORF1 to ORF2, a fusion con- 
struct was made with the coat protein gene of brome mo- 
saic virus (BMV) 5' to the antizyme gene (Figure 2D). Ribo- 
somes initiate at the BMV AUG and terminate at the ORF1 
UGA to make a protein of 257 amino acid residues and 
a mass of 27,832 Da. If they switch to the +1 frame ORF2, 
they will make a full-length product of 416 amino acids 
with an approximate mass of 46 kDa (the exact mass will 
depend on where the shift in frame occurs, since this will 
change the amino acid composition). As shown in Figure 
2E (WT, no immunoprecipitation), two products of the an- 
ticipated sizes were synthesized from mRNA of this fusion 
construct. The larger protein was the same size as the 
main product of the in-frame control (Figure 2E, IN). Both 
products in the wild-type fusion construct were immuno- 
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Figure 3. Determination fAmino Acid Sequence of the Transframe 
Peptide Isolated from an In Vitro Translation Product 
(A) Relevant nucleic acid sequence and predicted amino acid se- 
quence. The sequence following the 5' factor Xa cleavage site is shown 
with residue numbers. 
(B) Amounts of labeled amino acids detected in each cycle of Edman 
degradation. [~S]Cysteine and [3H]proline were used in one experi- 
ment and [SH]serine in the other (peptide purification to be published 
elsewhere). 
precipitated with anti-BMV antiserum, and only the larger 
product reacted with the antibody specific to ORF2 of anti- 
zyme (Figure 2E, center). These results ensure that the 
full-length product of the wild-type fusion is translated from 
two different reading frames and strongly suggest frame- 
shifting into the +1 frame. The efficiency of the shift can be 
determined from the ratio of radioactivity of the terminated 
and full-length products after calibrating the numbers of 
amino acid residues labeled in the two products. Spermi- 
dine has a nonspecific inhibitory effect on translation, so it 
is necessary to normalize the results to the total translation 
observed. The absolute amount of the frameshift product 
did not increase significantly and even decreased with 
higher concentrations of spermidine. After normalization, 
the shift efficiencies were 5.4% without polyamine addi- 
tion and 19.0% with addition of 0.6 mM spermidine. (There 
is variability in the quantitative polyamine stimulation, prob- 
ably reflecting differences in reticulocyte lysates and the 
nature of the 5' sequences in the mRNA. More experi- 
ments are needed to clarify these issues.) 
5' Deletion Analysis 
Signals for programmed frameshifting generally consist 
of the actual shift site plus nearby cis-acting sequences 
in the mRNA that stimulate the frameshift (Atkins et al., 
1990). To narrow the regions containing these signals, 
several deletion mutants of the BMV coat-antizyme fusion 
were tested for frameshifting (Figure 2E, rig ht panel). Dele- 
tions of the antizyme sequence to nucleotide 102 (A 1-102) 
or 153 (A1-153) did not significantly change the frameshift 
efficiency. Although the efficiency dropped, the M-195 
construct hat lacked all of ORF1 but the last three codons 
still exhibited a significant level of frameshifting (38% of 
the wild-type fusion). This result puts the likely frameshift 
site within the last three codons of ORF1, just at the end 
of the overlap region. It also raises the possible existence 
of a stimulatory element located within nucleotides 154- 
195, which will be discussed below. 
Amino Acid Sequence of the Transframe Peptide 
To pinpoint the change in reading frame, the amino acid 
sequence was required. However, sequencing of anti- 
zyme from cells is difficult, because the protein is present 
in only very small amounts. Simple N-terminal sequencing 
of radiolabeled, in vitro synthesized protein is difficult, 
since the predicted shift site is so far into the molecule. 
instead, an engineered form of radiolabeled protein syn- 
thesized in a reticulocyte lysate was sequenced. RNA was 
made in vitro from a construct with the last four codons 
of ORF1 (to nucleotide 268, which includes the presumed 
shift site and all the downstream sequence necessary for 
the efficient frameshifting as shown below) flanked by two 
cassettes specifying recognition sites for the factor Xa pro- 
tease, which cleaves on the C-terminal side of Ile-Glu- 
Gly-Arg, The 5' factor Xa site was positioned such that 
three amino acids remain from ORF1 after cleavage (Fig- 
ure 3A). The 3' cleavage site was positioned to reduce the 
size of peptide to be sequenced, thereby minimizing the 
background during Edman degradation. The mRNA was 
translated in a reticulocyte lysate in the presence of both 
[35S]cysteine and [3H]proline and, in a separate experi- 
ment, [3H]serine. The frameshift products together with 
the termination product were purified by glutathione- 
Sepharose column chromatography and digested with fac- 
tor Xa. The transframe peptides were then isolated with 
reversed-phase high performance liquid chromatography 
and subjected to automated Edman degradation (Figure 
3B). Cysteine was found in cycle 2, serine at cycle 3, and 
proline in cycles 6, 8, 9, and 13, to give the sequence 
X-Cys-Ser-X-X-Pro-X-Pro-Pro-X-X-X-Pro. Factor Xa cleav- 
age at arginine is predicted to leave cysteine as the second 
amino acid and serine as the third in the zero frame as 
found. The prolines at 6, 8, 9, and 13 are all predicted by 
the +1 reading frame, and therefore the frameshifting must 
be +1 but not -2  or +4, and so forth. Readthrough of the 
UGA terminator is ruled out, since cysteine (specified by 
UGU at the next position to the terminator in the zero 
frame) is not found in cycle 5. The reading frame must have 
changed either at the serine codon before the terminator or 
at the terminator: the later case could be achieved only 
if the terminator is decoded as a sense codon followed 
by immediate frameshifting, but this seems unlikely, as it 
requires two nonstandard events. We conclude that the 
last codon of ORF1, UCC, is the site of the +1 change 
in reading frame. While the results all point to ribosomal 
frameshifting, editing out of one base in the mRNA at this 
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Figure 4. Mutational Analysis of the Frameshift Context 
The wild-type (WT) sequence, separated as codons, is shown in the 
bottom boxes. Each nucleotide or the termination codon was mutated 
to ones indicated above. Translation was carried out in the reticulocyte 
lysate supplemented with 0.6 mM spermidine. Frameshift efficiencies 
relative to the wild type were calculated from data obtained by phos- 
phorimaging, normalizing tothe sum of the termination and frameshift 
products, taking into account the number of methionine r sidues. The 
values are averages from at least wo clones. The frameshift efficiency 
of the wild-type construct was 17.7% - 1.4o. 
site cannot a priori be discounted. Direct examination of 
the sequence of mRNA after protein synthesis showed no 
editing (less than one tenth of the required efficiency). 
Mutational Analysis of the Frameshift Context 
Various mutations in the frameshift region of the BMV 
coat-antizyme fusion construct were compared for frame- 
shift efficiency in a reticulocyte lysate. Deletions of each 
one of the last three codons of ORF1, namely, A196-198, 
A 199-201, and A202-204, gave frameshift efficiencies of 
46%, 37%, and 14% of the wild-type fusion, respectively. 
Substitutions for each nucleotide in this region were also 
tested (Figure 4). Any mutations of nucleotide 201 or 5' 
to it, i.e., upstream of the last codon of ORF1, did not sub- 
stantially affect the frameshift efficiency, except changing 
U196 to a G, which decreased frameshifting and inciden- 
tally created a run of five Gs. Surprisingly, the first position 
of the last codon, U202, could also be changed with no 
more than 30% decrease in frameshifting efficiency. 
Changing the first codon base alters the tRNA specified, 
indicating that more than one tRNA can cause this frame- 
shifting. Substitutions at the second and third positions of 
the last codon resulted in a greater decrease, and the mu- 
tation of C203 to a G particularly diminished the frameshift 
activity, consistent with involvement of these bases in 
tRNA interaction in the frameshift event. 
The results from sequence changes 5' to the shift site 
suggested that there may be an unidentified stimulatory 
element. The C201 to G mutation did not show any effect 
and creates a context with UGG immediately 5'to the UCC 
shift site. However, the mutant A199-201, described 
above, also brings UGG adjacent to the shift site UCC 
and has 37% activity. Furthermore, the U 196 to C mutation 
creates the sequence CGG UGC UCC and has 82% activ- 
ity, whereas the A196-198 mutant creates the sequence 
CGG UGC UCC and has 46% activity. These results are 
difficult o explain, in connection with the decrease of the 
frameshift activities in the A1-195 construct described 
previously, but may suggest an additional sequence ele- 
ment for efficient frameshifting 5' to the nucleotide 195, 
whose distance to the shift site is crucial. 
Downstream Stimulators 
When a shift site and a termination codon are immediately 
adjacent, the termination codon often acts as a stimulator 
in programmed frameshifting (Weiss et al., 1987; Curran 
and Yarus, 1988; Brault and Miller, 1992) and in low level 
frameshifting seen with test constructs (Weiss et al., 
1990). As shown in Figure 4, any substitution of the UGA 
termination codon with sense codons severely diminished 
frameshifting. On the other hand, changing it to the other 
termination codons, UAG and UAA, only slightly de- 
creased the frameshift, to 82% and 73%, respectively, of 
the wild-type fusion. Replacement of the nucleotide imme- 
diately 3'to the stop codon did not alter the shifting signifi- 
cantly. However, there may be a mild preference for U or 
C rather than A or G at this position. These results show 
that the termination codon of ORF1 is one of the important 
stimulators. In all the mutants of the termination codon 
tested, the frameshifting was increased by spermidine ad- 
dition (data not shown). 
Stimulators for -1 frameshifting, particularly in coronavi- 
ruses and retroviruses, are often pseudoknots located 
downstream of the shift site (Brierley et al., 1989; ten Dam 
et al., 1990; Chamorro et al., 1992). The tertiary structure 
of a pseudoknot has a stem-loop with nucleotides of the 
loop region paired to nucleotides downstream of the stern 
to form a second stem (Pleij et al., 1985). Antizyme mRNA 
sequence reveals a potential pseudoknot just 3' to the 
termination codon of ORF1 (Figure 5A), even though so 
far no examples of +1 frameshifting are known to be ac- 
companied by downstream RNA structure. The down- 
stream stimulator(s) for frameshifting was delimited by de- 
letion of the sequence 3' of the pseudoknot with retention 
of full frameshift activity (Figu re 5B, A269-682). If the dele- 
tion was limited to the potential pseudoknot region (A209- 
268), frameshifting decreased by 60%, suggesting the 
presence of a stimulator in this sequence. These results 
combined with the 5' deletions circumscribed the essential 
stimutatory signals as being located within the region of 
nucleotides 205-268. Deletions of various parts of this 
region also resulted in decreased frameshift activities (Fig- 
ure 5B), but the roles of potential stems were not clearly 
delineated, perhaps because of the complexity of other 
possible conformations. 
The stems of the proposed pseudoknot were tested di- 
rectly by specific mutations. The 5' side stem ($1) is di- 
vided by a pair of bulged-out nucleotides into two 6 nt 
stems (Figure 5A). Each half of these stems was substi- 
tuted individually by its complementary sequence to block 
potential base pairing. For the 3' side stem ($2), only two 
nucleotides in the stem were replaced, since chang!ng six 
nucleotides creates an in-frame terminator. Each of the 
substitutions resulted in decreased frameshifting by ap- 
proximately half. When double complementary changes 
were made so that base pairing was restored, frameshift- 
ing was restored. Conversion of the bulging bases in $1 to 
a GC pair did not alter frameshift efficiency (C-S1). These 
results provide evidence that the predicted pseudoknot 
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Figure 5. Stimulatory Effect of Downstream Sequence 
(A) A potential pseudoknot s ructure. The termination codon of ORF1 is boxed. 
(B) Mutational nalysis of the pseudoknot region. Relevant nucleic acid sequence of the wild-type construct (WT) is shown with the stem regions 
boxed. Open bars of the mutation constructs denote regions identical to the wild-type sequences, and closed bars denote deleted regions. Nucleotide 
substitutions are indicated. Frameshift efficiencies were measured as described in the legend to Figure 4. 
actually forms to enhance frameshifting. Deletion of the 
pseudoknot region from a construct containing a sense 
codon in place of the UGA codon does not further de- 
crease the low level of observed frameshifting when com- 
pared in the presence of exogenous spermidine (Figure 
5B, A209-268 GGA and A209-268UGU). In the absence of 
added spermidine, frameshifting was not detectable with 
these mutants (data not shown). Spermidine stimulated 
frameshifting (approximately 3-fold) whether or not the 
pseudoknot was present, whether or not the stop codon 
was present, and with or without deletions 5' to the stop 
codon (data not shown). 
A Sequence with the Shift Site and the Pseudoknot 
Directs Frameshifting and Stop Codon 
Readthrough in a Foreign Context 
The results presented above indicate that the essential 
frameshift signals consist of the last few codons and the 
stop codon of ORF1 and the downstream pseudoknot. 
Fusion clones were devised to see whether this region is 
sufficient for specific +1 frameshifting in a foreign context. 
These constructs, and rearrangements of them, also test 
the ability of this region to promote specific -1 frameshift- 
ing and stop codon readthrough. A fragment spanning the 
last five codons of ORF1 and the pseudoknot (nucleotides 
190-268) was cloned into a vector, pGB01 (see Experi- 
mental Procedures), between an upstream reporter, gluta- 
thione S-transferase (GST), and a downstream reporter, 
rabbit ~-globin (Figure 6A). In this construct, pGB-103, the 
I~-globin gene was fused to this fragment of antizyme 
mRNA so that shifting into the +1 frame was required for 
its expression. This fusion gene was transcribed with T7 
RNA polymerase and translated in a reticulocyte lysate 
(Figure 6B). The 45 kDa protein that migrated with the 
product of an in-frame construct results from +1 frame- 
shifting. The 27 kDa termination product corresponds to 
GST plus the fragment of ORF1. The 31 kDa product is 
of the expected size for readthrough of the ORF1 UGA 
terminator. However, -1 frameshifting would give an inter- 
mediate-sized protein of 28 kDa. The clone was re- 
arranged in order to focus on -1 frameshifting and read- 
through. The ~-globin gene was placed in either the zero 
(pG B-R01) or -1 (pG B-T01) frame with respect to the GST 
gene (Figure 6B). pGB-R01 encoded two products, a 33 
kDa protein predicted from +1 frameshifting and a 45 kDa 
product from readthrough, pGB-T01 encoded a 31 kDa 
+1 product and a 33 kDa readthrough product. Neither 
revealed the predicted -1 frameshift product. The addi- 
tion of spermidine increased the relative amounts of the 
frameshift and readthrough products, but with different 
optimal spermidine concentrations (Figure 6B). At 0.8 mM 
of added spermidine, +1 frameshifting was 9.9%, com- 
pared with 1.0% without added spermidine. For read- 
through, maximal efficiency was 8.3% with 0.6 mM of 
added spermidine compared with 2.6% without. The 79 
nt fragment of antizyme is sufficient o promote polyamine- 
dependent, specific +1 frameshifting when transplanted 
to a new context, but not -1 f.-ameshifting. The fragment 
does, however, promote readthrough of its UGA stop co- 
don, but this is unlikely to be of biological importance. (In 
the BMV coat-antizyme fusion, where the context is more 
similar to the natural gene, a product with the expected 
30 kDa size of that derived from UGA readthrough was 
not detected.) 
Discussion 
Regulation of Antizyme Expression 
The finding that ribosomal frameshifting is used in expres- 
sion of a mammalian gene is a major extension of our 
knowledge of the utilization of recoding. The mechanism 
for regulation seems to be general: recent results indicate 
that the antizyme mRNAs from human and Xenopus laevis 
also require frameshifting for their expression (unpub- 
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Figure 6. Expression of Constructs with Antizyme Frameshift Cas- 
sette in a GST-13-Globin Fusion 
(A) Construct used in this experiment. The antizyme sequence, nucleo- 
tides 190-268 (solid bar), was inserted into the pGB01 vector. The 
I~-globin frame is +1 (pGB-103), 0 (pGB-R01), or -1 (pGB-T01)with 
respect to the GST frame. GPD and T7 denote the GPD and T7 pro- 
moters. 
(B) In vitro translation products. T7-generated RNAs were translated 
in the presence of indicated amounts of exogenous spermidine, and 
the products were separated on SDS-PAGE (11%). The positions of 
÷1 and -1 frameshift (FS), readthrough (RT), and termination (TERM) 
products of each construct are indicated on the left. IN denotes the 
in-frame constructs, from which the full-length fusion proteins were 
produced without frameshifting or readthrough. 
lished data). The role of this recoding is to provide an 
elegant autoregulatory circuit. Less is known about an ad- 
ditional regulatory s stem(s) where antizyme somehow re- 
presses a polyamine transporter (Mitchell t al., 1994; Su- 
zuki et al., 1994). 
The frameshifting stimulated by polyamines results in 
an increase in the amount of antizyme, which lowers intra- 
cellular polyamine levels by promoting turnover of a key 
enzyme in polyamine synthesis, ODC. Functional anti- 
zyme is encoded in ORF2 alone, and the role of ORF1 
seems not to be for its protein product per se, but rather 
to provide for recoding regulation by polyamines. Cells 
stably transfected with ORF2 supplied with an in-frame 
initiator codon showed antizyme activity that was not stim- 
ulated by exogenous polyamines (Murakami et al., 1992a). 
However, the relatively large size of ORF1 (depending on 
which AUG is used for initiation, 68 or 35 codons) makes 
it likely that ORF1 is doing more than just providing a 
ribosome start site in a different frame. In the only other 
case of autoregulatory frameshifting, E. coil RF2, the 
ORF1 is only 25 codons. 
Frameshift Mechanism 
Frameshifting for the expression of antizyme in the reticu- 
Iocyte lysate is +1, occurring at the UCC serine codon 
immediately before the ORF1 UGA terminator. It is also 
highly specific. Frameshifting into the other frame (-1) is 
not detectable. 
The known cases of +1 ribosomal frameshifting fall into 
two general classes: in the first class, the mRNA permits 
peptidyl-tRNA to slip ahead by 1 base at the shift site and 
re-pair in the new frame; in the second class, the mRNA 
allows a translocation step of 4 bases at the shift site. In 
the antizyme case, re-pairing would require serine tRNA 
first to pair with UCC, then to move ahead one to CCU, 
where it could pair with only the last two bases. Imperfect 
pairs at a re-pairing position are seen in several frameshift- 
ing cases (reviewed by Atkins and Gesteland, 1995). How- 
ever, with antizyme, in vitro mutational analysis shows that 
re-pairing is not obligatory and with some of the mutants 
cannot occur. When the UCC is changed to UCG, a signifi- 
cant level of frameshifting (30%) was still observed (Figure 
4). This UCG-serine codon is decoded by other serine 
isoacceptors with anticodons of 3'-AGU-5' (with or without 
a modification of the U) or 3'-AGC-5'. Neither of these 
tRNAs can pair in any of their anticodon positions to the 
+1 frame, CGU, making re-pairing unlikely, This is further 
supported by results of changing UCC to ACG, where 
again no base pairing is possible, yet the reduction in 
frameshifting efficiency is only 50%. Several possible 
mechanisms that do not involve re-pairing are compatible 
with the present data and cannot yet be distinguished (of. 
Farabaugh et al., 1993). 
Stimulatory Signals 
Two stimulatory elements in antizyme mRNA have been 
identified for mammalian ribosome frameshifting. A stop 
codon at the end of ORF1 is crucial, but its identity (UAA, 
UGA, or UAG) is less important. The preliminary evidence 
here supports the participation of the downstream pseu- 
doknot shown in Figure 5A. While downstream structures 
have been shown to be stimulatory for -1 frameshifting 
and stop codon readthrough, this is the first example of 
involvement in +1 frameshifting, though the 2.5-fold effect 
is considerably less than is seen in the -1 cases. The 
spacing between the shift site and the pseudoknot is 5 nt. 
However, since the UGA codon occupies the A site when 
the shifting occurs, the relative spacing between the shift 
site and the pseudoknot is 2 nt. It is much less than the 
6-9 nt usually found in -1 frameshifting and readthrough 
(except prokaryotic selenocysteine [Heider t al., 1992]). 
However, the existence of the UA pair at the base of $1 
may not be concluded from the present data. In addition, 
two alternative pseudoknots with different $1 can be 
drawn that would have spacing of 12 nt. One does not 
have the bottom half of $1. The other has an $1 of seven 
CG pairs composed of nucleotides 217-224 and 239-247, 
allowing three bulged-out nucleotides. However, the avail- 
able data support the model shown (Figure 5A), with short 
spacing. The results of the compensatory experiments 
suggest that the primary sequence of the stems of the 
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pseudoknot region may not be important, similar to the 
other cases of frameshifting. 
Mechanism of Polyamine Stimulation 
of Frameshifting 
It is not surprising that small, polycationic polyamines in- 
teract with nucleic acids and have general effects on trans- 
lation (Atkins et al., 1975; Tabor and Tabor, 1984). In anti- 
zyme decoding, polyamines stimulate frameshifting (in 
vivo and in vitro, at physiological concentrations) to afford 
autoregulatory control. Whether the polyamine effect is 
specific for antizyme mRNA or perhaps for all +1 frame- 
shifting is not known. It may be specific for +1 frameshift- 
ing, since at least with mouse mammary tumor virus gag- 
pro -1  frameshift, no stimulation is seen (unpublished 
data). In yeast, mutational alteration of polyamine metabo- 
lism influences frameshifting, but effects of specific poly- 
amines remain to be resolved (Balasundaram et al., 1994). 
Irrespective of whether the polyamine effect is specific 
for antizyme mRNA, somehow sequences in antizyme 
mRNA set up a frameshift event that is responsive to poly- 
amine concentrations. Can a polyamine-specific effector 
sequence be delimited in the mRNA? One candidate might 
be the downstream pseudoknot. But constructs without 
the downstream region are still stimulated by spermidine. 
Spermidine did not have its effect through the termination 
codon or upstream sequences, either. This points toward 
polyamines having their effect through distortion of the 
decoding site, including perhaps the tRNA, to allow frame- 
shifting. Whatever the detailed mechanism, it does seem 
remarkable that the sequences in an mRNA can set up 
a r ibosome to respond to the concentration of small, 
ubiquitous molecules and alter its mode of reading the 
genetic code. 
Experimental Procedures 
cDNA Cloning and Sequencing 
Oligo(dT)-primed cDNA was synthesized from poly(A) + RNA from the 
livers of Sprague-Dawley rats by use of a kit (Boehringer) and inserted 
into the XZAPII vector (Stratagene) through EcoRI adaptors (Promega) 
to construct a library. Nine positive clones were selected out of 2 x 
105 recombinants by plaque hybridization with a probe of the partial 
length antizyme cDNA Z1 (Matsufuji et al., 1990b). These clones were 
converted to pBluescript plasmids by in vivo excision. Two of the 
longest clones, ZZ5 and ZZ4, were sequenced entirely on both strands 
with synthetic primers or on subclones of restriction fragments. Se- 
quencing was carried out with the dideoxynucleotide chain termination 
method on double-stranded plasmids. 
Plasmid Constructions 
The plasmid for in vitro expression of antizyme, termed NE, has three 
parts: first, a 0.97 kb BamHI-EcoRI fragment of ZZ5 cDNA (containing 
the nucleotide 24 in Figure 1 and all the following sequence through 
the 3' EcoRI linker of the cDNA); second, a duplex of synthetic oligonu- 
cleotides with sequences 5,-AGCTTGCGGCCGCCATGGTGAAAT- 
CCTCCCTGCAGCG and 5'-GATCCGCTGCAGGGAGGATTTCGAC- 
CATGGCGGCCGCA, compatible with Hindlll and BamHI sites; and 
third, the larger EcoRI-Hindlll fragment of pGEM4Z (Promega). The 
in-frame mutant lacking T205 (AT205) was produced by PCR-based 
site-directed mutagenesis (Higuchi et al., 1988). A plasmid with the 
BMV coat protein-antizyme fusion, C3NE, was prepared as follows. 
The HindllI-BamHI fragment of NE was first replaced by a duplex of 
synthetic oligonucleotides 5'-AGCTAGATCTGAGAAGCTTGGTGAA- 
ATCCTCCCTGCAGCG and 5'-GATCCGCTGCAGGGAGGATTTCA- 
CCAAGCTTCTCAGATCT. A fragment corresponding to nucleotides 
1242-1816 of BMV RNA3 (Ahlquist et ai., 1981) was amplified by PCR 
on the plasmid pB3TP7 (Janda et al., 1987) (provided by Dr. J. Bujarski) 
with two immediately flanking restriction sites, 5'-Bglll and 3'-Hindlll, 
introduced to the primers. The PCR fragment was digested with Bglll 
and Hindlll and inserted into the Bglll and Hindlll sites of the modified 
NE plasmid. 5' deletion constructs were prepared by replacing the 
smaller HindllI-Nhel fragment (279 nt) of C3NE with HindllI-Nhel- 
digested PCR fragments on ZZ5 by use of 5' primers with the sequence 
5'-GGAAGCTTG, followed immediately by antizyme sequences, nucle- 
otides 103-122, 154-174, or 196-214, and a 3' primer complementary 
to nucleotides 317-337. To introduce various mutations at the shift 
site or the pseudoknot region, nucleotides 191 and 257 of C3NE (num- 
bered as in Figure 1) were changed by PCR mutagenesis to C and 
T, respectively, creating Apal and Bcll sites. ApaI-Bcil or ApaI-Nhel 
fragments of this plasmid were then substituted by pairs of oligon ucleo- 
tides with mutant sequences. 
Details of construction of pGG75 will be described elsewhere and 
are available upon request (N. M. Wills, M. G. Sandbaken, J. F. A., 
and R. F. G., unpublished ata). In brief, a PCR fragment containing 
5' to 3', a Bglll site, T7 promoter, the GST coding region (including 
the downstream thrombin recognition site from pGEX-2T [Pharmacia]), 
and a BstEII-XhoI-KpnI-BamHI polylinker was digested with Bglll and 
BamHI and inserted into the BamHI site of the yeast expression vector 
pG-1 (Schena et al., 1991). In this construct, pGG75, GST is tran- 
scribed from either the GPD or T7 promoter. 
pGB01 (Figure 6A) was constructed by introducing the rabbit 
J~-globin gene into the unique BamHI site of pGG75. The fragment 
was prepared by PCR on pOGl~17 (G6rlach et al., 1989, provided by 
Dr. J. Schickinger via Dr. M. F. Tuite) and contained the sequence from 
the second codon of ~-globin through the Bglll site 3 nt downstream to 
the end of the ORF, with a BamHI site introduced immediately 5' of 
the second codon. Sequences of the antizyme frameshift window, 
corresponding to nucleotides 190-268, were amplified with PCR and 
inserted into the BstEII and Kpnl sites of pGB01 (Figure 6A). The 
antizyme sequence was flanked by two As at 5' and either GG (pGB- 
103, for monitoring +1/-2 frameshifting), CGG (pGB-T01, for-1 frame- 
shifting) or G (pGS-R01, for readthrough) at 3' between the restriction 
sites to adjust the reading frame. For monitoring -1 frameshifting, the 
nucleotide corresponding to A227 (Figure 1) was also replaced by a 
G. This changed the in-frame UGA codon to UGG and did not affect 
the pseudoknot formation. The construct used for amino acid sequenc- 
ing in Figure 3, pGB-F01, is similar to pGB-103 and has an insert 
consisting of antizyme sequence 193-268 flanked by two oligonucleo- 
tides specifying factor Xa sites, 5'-AAATCGAAGGT at 5'and 5'-ATTGA- 
AGGTAGAATCGG at 3'. 
For each construct used in this paper, two independent clones were 
verified by DNA sequencing, and both were subjected to expression 
experiments. 
In Vitro Transcription and Translation 
DNA templates for in vitro transcription were either linearized plasmids 
(digested with EcoRI) or PCR fragments of the plasmids amplified with 
an upstream primer, 5'-GGCTCGAGTAATACGACTCACTATAGGG, 
containing the T7 promoter sequence, and downstream primers com- 
plementary to the sequence corresponding to the end of the ORFs, 
which are followed by the tetranucleotide 5'-TAGG. Templates with 
these two methods gave identical results. RNAs were synthesized with 
T7 polymerase (Stratagene or Promega) according to the instructions 
of the supplier. Translation mixture (15 id) contained 0.6 pmol of the 
mRNA, 15 ~tCi of [3SS]methionine (>1000 Ci/mmol), and 10.5 ~tl of 
ribonuclease-treated rabbit reticulocyte lysate (from Wako Chemicals 
for experiments in Figures 2A-2C or Promega for other experiments) 
with or without addition of polyamines. After incubation at 30°C for 
45 rain, 1 ~1 of 1 p~g/~l RNase A was added, incubated for a further 
10 rain, and analyzed by SDS-PAGE. For immunoprecipitation (Ka- 
meji and Pegg, 1987), either 20 ~g of anti-antizyme IgG (Matsufuji et 
al., 1990b) or control rabbit IgG or 2 ILl of anti-BMV rabbit serum (ATCC) 
was added and incubated for 15 rain. Protein A-Sepharose (Phar- 
macia, 40 I~1 of 50% slurry) was then added and mixed for 1 hr. The 
pellet was washed with 0.5 ml of imm unoprecipitation buffer five times, 
suspended in sample buffer, heated, and subjected to SDS-PAGE. 
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Translation of albumin was carried out with 0.5 ~_g of poly(A) ÷ RNA 
from rat liver followed by immunoprecipitation with anti-rat albumin 
(Kameji and Pegg, 1987). Gels were processed for fluorography by 
using Amplify (Amersham) in the experiments hown in Figures 2A- 
2C, or for autoradiography in the other experiments. The exposure 
times were 6-12 hr. The products were quantitated either by direct 
counting of excised bands or by scanning the gel on a Phosphorlmager 
(Molecular Dynamics). 
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